Supplementary Materials and Methods

In vitro cytotoxicity assay of human normal cells
fetal bovine serum (Gibco) and 1% penicillin/streptomycin (North China Pharmaceutical Co., Shijiazhuang, China) in a humidified incubator (Thermo Fisher Scientific, Waltham, MA) with 5% CO 2 at 37 ℃. The cytotoxicity of Zapadcine-1 was analyzed by the CellTiter-Glo® Luminescent Cell Viability Assay (Promega, G7572).
Zapadcine-1 stability in human plasma
Zapadcine-1 at concentrations of 0.2 to 200 µg/mL was spiked in pooled human K2-EDTA plasma and incubated at 37 °C for a time course of 1, 2, 4, 8, 24, 48, 72, 96, 120 and 144 h. The free-form MMAD in the plasma samples were determined by LC/MS/MS and calculated according to the following formula: Free MMAD (%) = actual generated MMAD concentration / total MMAD concentration ×100%, and total MMAD concentration = Zapadcine-1 theoretical molar concentration × DAR × MMAD molecular weight. Mass spectrum conditions： A positive ion MRM scan was used using a Trip Quad 5500 mass spectrometer with an ESI source. 
Liquid chromatography mass spectrometry (LC/MS/MS) analysis
Histopathology and immunohistochemistry analysis
Mice or cynomolgus monkeys were euthanized after the experiments. The animal heart, liver, lung and kidney were collected and fixed in 10% neutral buffered formalin for 48 h for preparing 5 µm thick sections. The sections were dewaxed, rehydrated, and stained with hematoxylin and eosin (H&E) dye. The pathological changes in the heart tissues were observed under a light microscope (×400 magnification, Olympus, Tokyo, Japan). Immunohistochemical staining was accomplished using the methods previously reported by Rocio Ramos-Medina et al.
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